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Host and pathogen interactions like that of Helicobacter pylori and the human 
CEACAM1 N-domain are heavily reliant on specific amino acid interactions. Even a 
single change in a sequence can result in drastic changes in binding affinity for the 
interaction on either side. Understanding which amino acids create these significant 
bonds is key to developing treatments to common illnesses associated with H. pylori 
infection. CEACAM 1 interacts with H. pylori strains via one of two similar surface 
proteins called HopQ Type I and HopQ Type II. These proteins share a 70% sequence 
homology in the binding domain yet their relative binding affinities to H. pylori strains 
are relatively unknown. The goal of this study is to compare binding affinities of these 
two proteins with a variety of CEACAM 1 variants across humans and primates in order 
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The human body is full of resources which allow all our cells to continue 
functioning every second of our lives. Some of these resources are nutrients such as 
sugars or carbohydrates which are floating around in our blood while others, like the 
iron in our red blood cells, are locked away behind cell walls. Other resources include 
certain cellular machinery which allow for general function and replication. Although 
this plethora of resources is important for our survival, it is not without its 
consequences. Many pathogens require these resources for their own survival and 
replication, which makes humans a habitable environment for many pathogens. 
To prevent colonization by pathogens, humans have evolved defensive barriers 
throughout the body. This includes cellular membranes, mucosal linings, immune 
system proteins and diverse pH environments. However, diseases caused by pathogen 
colonization still occur, as certain pathogens have acquired the ability to move around 
these protective measures. One common battleground which either prevents or allows 
invasion from a pathogen is the cell wall. Pathogens have found a number of ways to 
bypass the cell wall including some that use toxins such as pore-forming toxins(PFTs) 
to break open the lipid bilayer that makes up the cell wall(Gonzalez et al., 2008). 
Opening the cell wall allows the vital nutrients locked within a cell to flow into the 
extracellular space for pathogen consumption. Another common technique used by 
pathogens to infiltrate cellular membranes is the use of proteins to fuse with the lipid 
bilayer thus allowing the insertion of pathogen DNA, RNA, or proteins(Arias & 
Dubois, 2017). A final approach that pathogens have developed to neglect our cell’s 




imbedded in the lipid bilayer of a cell and thus can serve as an access point into the 
intracellular region. Cells with surface proteins that are unable to prevent invasion are 
infected and allow the successful pathogen strain to proliferate using the nutrients and 
cellular machinery housed inside the cell. If this pathogen-favored interaction occurs 
frequently enough this could weaken or kill the host. This decrease in fitness for the 
host due to this protein which allows pathogen binding could lead to selection against 
this specific protein in the population. Contrary to this outcome, if the surface protein 
prevents invasion, then the pathogen is unable to acquire nutrients and will likely die. 
Like in host proteins this could cause this pathogen protein to be selected against in the 
population in favor of a slightly different protein which allows binding to occur. This 
type of interaction results in a situation where on a population scale both human surface 
proteins and pathogen adhesion proteins experience rapid coadaptation. This rapid 
change in proteins is due to the continual shift of the dominant genotype of human 
surface proteins and pathogen strains as previous genotypes are selected against by 
successful competitors. This evolutionary cycle based on biotic interactions was first 
described as the Red Queen Hypothesis (VAN & L, 1973). This hypothesis describes 
how biotic factors can drive a form of zero sum evolution where species are constantly 





Figure 1: Host-pathogen coadaptation due to chronic interactions (Baker et al., 
Unpublished) 
 Host-pathogen interactions can result in continual coadaptation from both proteins. In 
this instance binding is advantageous for the bacterial antagonist which drives a shift in 
the host protein. A lack of binding is advantageous for the host protein and drives a 
shift in the bacterial antagonist. This results in a roughly net-zero relative fitness gain 
for both species. 
The factor that primarily determines whether invasion of a pathogen occurs, 
when interacting with a surface protein, is the ability of that pathogen’s adhesion 
protein to bind to the surface protein. This binding is orchestrated by hydrophobic or 
hydrophilic amino acid interactions, disulfide bonds, hydrogen bonding, and many other 
types of interactions. The binding affinity of these highly sensitive interactions can be 
significantly altered by even a single amino acid change caused by a nonsynonymous 




to synonymous mutations greater than one, this can indicate that positive selection is 
occurring. Positive selection is the rise of an advantageous mutation in the genotype of 
a population due to selection factors creating an environment where that mutation 
significantly increases fitness of its host. 
Although rapid nonsynonymous changes in human surface proteins allow for a 
reduction in the binding affinity of pathogen proteins these receptors typically exist to 
interact with other host proteins to perform vital functions. These host-host interactions 
are just as sensitive as host-pathogen interactions, so the nonsynonymous changes that 
prevent invasion can also result in a loss of function for that protein.  
Overall, host-pathogen interactions are a contributing force to shaping the 
genotypes of human populations across the world. Identifying host-pathogen 
interactions, and the consequences resulting from this interaction is an important area of 
study that can shed light on how these interactions can be prevented. Within this field of 
study, an example of particular interest involves human CEACAM proteins. CEACAM 
(CarcinoEmbryonic Antigen-related Cell Adhesin Molecules) are a family of proteins 
involved in cell-cell recognition and several cellular processes including T-cell 
proliferation and insulin homeostasis(Figure 2:Kuespert et al., 2006). It was observed 
that many of these proteins were experiencing positive selection in their N-domain 
which is a common binding spot for other host proteins and pathogens(Adrian et al., 





Figure 2: CEACAM family proteins (Adapted from Grey-Owen and Bloomberg, 2006) 
Extracellular CEACAM proteins all contain a N-terminus protein(Yellow) which is a 
frequent binding spot for pathogen and host proteins. Many proteins have additional 
similar extracellular units(orange) and a transmembrane domain(green). 
One bacterium that is likely contributing to this positive selection in CEACAM 
proteins is Helicobacter pylori(H.pylori). This bacterium is currently estimated to 
colonize the stomach of 50% of the world’s population and has been found to have been 
coevolving with humans for 50,000 years(Atherton & Blaser, 2009). H. pylori utilizes 
an adhesion molecule called HopQ to bind with a variety of host CEACAM 
proteins(Bonsor et al., 2018). Two families of genetically and geographically distinct  
HopQ have been identified and are commonly referred to as Type I and Type II. On 
average, Type I and Type II strains share 70% amino acid homology in the binding 
domain, and Type I is typically found in the Middle East and Asia while Type II is 
typically found in the United States and Canada(Cao et al., 2005). A major distinction 
between the two strains of particular importance to the medical community is the 
presence of the Cag pathogenicity island or group of genes almost exclusively found in 




implantation of a protein called CagA if the strain has the group of Cag genes. This 
protein has been linked to a large increase in the risk of gastric cancer (Hatakeyama, 
2014). Some estimates suggest that this type of interactions with H. pylori causes one 
million annual cases of gastric cancer worldwide(Wroblewski et al., 2010). This 
resulting increased risk of gastric cancer lead the World Health Organization to label H. 
pylori the first bacterial carcinogen in 1994(Parkin et al., 2005). 
From a host-pathogen perspective this increased gastric cancer risk from 
H.pylori could act as a selection factor for individuals with CEACAM proteins that bind 
with HopQ. As there is positive selection on many CEACAM protein N-domains, the 
question became which CEACAMs are being bound by HopQ? It has been shown that 
both HopQ types will bind to CEACAM1, 3, 4, and 6(Javaheri et al., 2016). This same 
study reported that CagA insertion only occurred when HopQ attached to CEACAM 1 
which suggests H. pylori could be partially responsible for the rapid evolution in the N-
domain of human CEACAM1(Javaheri et al., 2016). It should be noted that 
CEACAM3, which aids granulocytes in recognizing and consuming bacteria that bind 
to other CEACAM proteins, could also be changing due to HopQ binding(Adrian et al., 
2019). Individuals with CEACAM 3 proteins that are not able to identify HopQ would 
not have the opportunity to stop an infection from occurring.   
When examining HopQ binding with the CEACAM1 N-domain the main area 
of binding seems to be in the C1ND region in CEACAM1 which binds with both 
isoforms of HopQ: Type I and Type II (Figure 3)(Moonens et al., 2018). Despite this 
binding interaction being well documented the specific amino acids that are essential for 




inhabit humans and higher primates; no published work has been done to compare 
binding affinity between HopQ types and different types of CEACAM1 proteins across 
higher primates and humans (Atherton & Blaser, 2009). If H. pylori strains that colonize 
humans were observed to bind to primate CEACAMs, this could demonstrate whether 
human specific H. Pylori would cause issues if transferred to primates, and it could also 
allow us to compare N-terminal amino acid sequences between binding and non-
binding CEACAM1s to locate important binding amino acids. To obtain this data the 
Barber lab has already examined binding of HopQ type I across several primate species’ 
CEACAM1s. They found that human HopQ type I strains G27 and J99 bound to 
CEACAM1s from chimps and gorilla (Baker, Unpublished data). Interestingly, they 
also found that bonobo CEACAM1 did not bind either type I strains while gorilla 
CEACAM1 bound with both strains. This is unexpected as bonobos are 
phylogenetically closer to humans than gorillas, which would suggest that bonobos are 
less likely to have diverged enough genetically to lose binding compared to gorillas. To 
examine whether the same CEACAM1 proteins show similar binding to the genetically 
distinct type II HopQ strains western blotting was done with the same primates and 
human HopQ type II strain Tx30a. This could allow comparison of the strains to 





Figure 3: Interaction of HopQ type I and Type II with C1ND region of CEACAM1 N-
terminus (Adapted from Moonens et al,. 2018) 
The H.Pylori alleles HopQ type I(Blue) and HopQ type II(Green) have a 70% 
homology in their binding region which translates to unique interactions with the C1ND 
region of the CEACAM1 N-terminus(Purple).  
To further explore why binding with CEACAM1 in bonobos was lost the Barber 
Lab created human and bonobo CEACAM1 mutants that switched amino acids which 
differed between the two proteins in areas of human CEACAM1 that were found to be 
experiencing positive selection(Figure 4). The mutants created are labeled humG85Q, 
bonQ85G, humNHI(61-63), and bonQLF(61-63) with lettering on the left noting the 
wild type amino acid replaced by amino acid letter noted on the right. The number 
represents the amino acid distance from the N-terminus. These mutants were paired 
with G27, J99 and Tx30a strains to observe if binding would occur. A recovery of 
binding in any bonobo mutants or a loss of binding in human mutants would strongly 
indicate that the switched amino acid was necessary for binding or responsible for lack 
of binding.  
A study done in 2019 identified 3 CEACAM1 mutants that interestingly were 
commonly found as a group and not independent, and comprised roughly 10% of 




Q89H which are numbered from the N-terminus of the CEACAM1 binding area. 
Although not directly associated with the primate panels these mutants could also offer 
insight into valuable binding sites for HopQ. These mutants were tested with G27, J99 
and Tx30a independently and also grouped together.  
 
Figure 4: Areas of positive selection found on human CEACAM1 N-domain (Adapted 
from Emily Baker) 
A 3-D representation of human CEACAM1 N-domain with sites found to be 
experiencing positive selection(blue). Although positive selection was found across 
CEACAM1 it is heavily concentrated in the N-domain which is a common site for 






To examine the qualitative ability of H. pylori to bind to primate CEACAM1 
proteins, human/bonobo CEACAM1 mutants, and CEACAM1 African mutants each of 
these respective protein’s N domain was tagged with a green fluorescent protein (GFP) 
for optimal visualization. After these proteins were expressed in mammalian cells, they 
were incubated with specific H. pylori strains in a pulldown assay. This assay allows for 
the interaction of two or more proteins for the eventual observation of binding if such 
affinity exists. After the interaction period these samples were washed and suspended in 
a laemmli buffer which caused the proteins to denature. The denatured proteins were 
then used in a western blot, a procedure which uses an electrical signal to pass samples 
through a gel to determine the relative size of DNA, RNA or protein samples based on 
distance traveled. After size determination the gels are transferred to a nitrocellulose 
membrane which can be used to administer antibody treatments. These treatments 
involved a primary antibody, which bound to the GFP attached to the CEACAM1 N 
domain proteins. After removing any unbound primary antibody via a wash, a 
secondary antibody that attached to the primary antibody was applied. This secondary 
antibody contained an enzyme that can produce visible light via chemiluminescence 
which could then be imaged using charge-coupled device digital imaging.  
CEACAM Protein Prep 
Primate CEACAM1 expression plasmids were transfected into Human 
HEK293T cells using the Lipofectamine™ 3000 transfection kit from Invitrogen 




collected and filter sterilized, and cells were collected and lysed. Expression of proteins 
was confirmed by western blotting. 
Bacterial strain growth conditions 
H. pylori type I strains G27 and J99 and type II strain Tx30a were plated onto 
horse blood agar plates, from glycerol stocks kept at -80o, which were then placed under 
aerobic conditions (10% CO2 at 37o) for 96 hours. Colonies were then removed from 
the agar and added to a brain-heart infusion broth prior to combination with CEACAM 
protein. 
Protein pulldown 
H. pylori cultures suspended in a brain-heart infusion broth were combined with 
GFP-tagged CEACAM 1 N-terminal domain proteins from varying primates at room 
temperature for 30 minutes while being rotated. The samples were then put through two 
cycles of a 1x PBS wash followed by being spun down in a centrifuge at 10000rpms for 
five minutes. A 20 to 1 mixture of BIO-RAD 1x laemmli sample buffer with 2-
mercaptoethanol was added to samples that were then boiled at 95o for five minutes.  
Western blot 
20µL samples of CEACAM1 protein with H. pylori bacterial cultures were 
loaded into Mini-PROTEAN TGX gels before electrophoresis. Separated proteins were 
then transferred to a nitrocellulose membrane. These membranes were incubated in 5% 
non-fat milk infused with primary antibody (monoclonal, anti-GFP mouse) for one 
hour(Figure 5). This was followed by three 1x PBS washes before incubation with the 




antibody (HRP- conjugated precision protein strep-tactin) for twenty minutes. The 
membranes were then washed with 1x PBS again before imaged using a 
chemiluminescent western blot imager (LI-COR Biosciences). 
 
Figure 5: Protein pulldown assay and western blotting procedure (adapted from Emily 
Baker) 
Various primate GFP-tagged CEACAM1 N-domains were incubated with individual 
strains of H. pylori. These were then washed with 1x PBS and spun down with a 
centrifuge. Binding was verified by soaking in 5% low fat milk with a GFP antibody 
derived from mice. This was followed by a secondary mouse antibody derived from 
goats. Input lanes contained pure GFP-tagged CEACAM1 N-domain while pulldown 





Western blots of the primate panel including H. pylori Type I strains G27 and 
J99 along with Type II strain Tx30a revealed similar binding between all three strains. 
 
Figure 6: Primate panel western blot data with H. pylori strains G27, J99, and Tx30a 
Primate CEACAM1 N-domain binding with HopQ type I strains G27 and J99 along 
with HopQ type II strain Tx30a showed that chimp and gorilla CEACAM1 N-domain 
bound all H. pylori strains. The lack of binding to bonobo CEACAM1 N-domain 
appears to be present in both types of HopQ despite a closer common ancestor than 
gorilla. Varying binding affinity should be carefully inferred from binding results. 
Western blots of the avaliable human and bonobo mutants showed no binding 




binding Tx30a. This was not matched by a gain of binding when bonobo CEACAM1 
swapped certain amino acids with human CEACAM1. Western blots of various 
combinations of the 3 common CEACAM1 N-domain mutants in certain African 
populations showed continued binding with Tx30a.  
 
Figure 7: Western blots of human/bonobo CEACAM1 mutant, and 3 African 
CEACAM1 mutants 
A loss of binding was observed with the human CEACAM1 proteins with bonobo 
amino acid inserts. Binding was not restored when bonobo CEACAM1 proteins had 
human amino acid inserts. Despite varying levels of prominence, all African 
CEACAM1 mutants bound Tx30a. Varying binding affinity should be carefully 






Observing that the HopQ type II strain Tx30a bound to the same primate 
CEACAM1 proteins as the Type II strains G27 and J99 is both exciting and surprising. 
The similar binding of type I and Type II HopQ strains despite only a 70% sequence 
homology suggests that both types have achieved unique, but similarly effective 
methods of binding. It should be noted that the nature of evidence from western blotting 
is qualitative so binding strength can only be estimated. It would be greatly informative 
in the future to use flow cytometry to obtain more quantitative binding affinities for 
comparison between primate CEACAM1 proteins. Flow cytometry measures the 
density of cell populations using light, and can also be used to detect binding of proteins 
if a control template is used for comparison. The lack of binding to orangutan, baboon, 
and squirrel monkey CEACAM1 is expected as these are phylogenetically distant from 
humans. The lack of binding to baboon that was already observed in type I strains G27 
and J99 is intriguing and deepens the curiosity surrounding what is causing rapid non-
synonymous mutations of CEACAM1 in bonobo populations. 
Although the data on bonobo mutants is preliminary and only includes part of 
Tx30a, if the data is correct, it could be very informative. The loss of binding in both 
humG85Q and humNHI shows that the original human amino acids are necessary for 
binding to occur. When this is paired with the lack of binding restoration in the 
bonQ85G and bonQLF this shows that the human amino acids in these positions are not 
sufficient for binding. This suggests that HopQ type II binding with human and bonobo 
CEACAM1 is supported by complex binding interactions from multiple points within 




The CEACAM1 mutant data including Tx30a is a truly interesting start to the 
process. Despite the lack of information from G27 and J99 the fact that HopQ type II 
binds with all mutants and mutant combinations is suggestive that other factors might 
be the cause of the evolution of these CEACAM1 mutants. If binding to HopQ still 
occurs this would suggest that the likely advantageous nature of these mutations, which 
presumably caused its emergence in the population, would be due to altering a different 
binding interaction. If no change in binding with HopQ has occurred, then no change in 
fitness would drive these mutations to become more prevalent in a population. This is 
purely speculative and could also be because the mutations occurred and provided no 
disadvantages and so remained in the population at lower levels. This would not explain 
why the mutants are commonly found to be paired instead of independent which 
suggest that some advantage was derived from these mutations the nature of which 
being unknown. It must also be mentioned again that this data is qualitative in nature 
and does not definitively show if subtler binding affinity changes are occurring. A 
lowering of binding affinity due to the mutations could provide some advantage and 





The obvious next step in this process is to continue the HopQ type I and type II 
comparisons with the human and bonobo mutations and the African population mutants. 
This will allow us to completely compare the two types of strains and what amino acids 
could be leading to any differences in binding. It could also allow us to observe if other 
amino acids that vary between human and bonobo CEACAM1 follow the pattern 
already seen with loss of function with the addition of bonobo amino acids to human 
CEACAM1, but no revival of binding with human amino acids added to bonobo 
CEACAM1. Continuing the examination of the African mutants with HopQ type I 
could show a difference in binding which suggests successful avoidance of HopQ type I 
strains by these mutants. If no difference in binding is found it would be important to 
examine whether other CEACAM protein such as CEACAM3 and CEACAM5, which 
also have been found to have common mutations, have different binding affinities to 
HopQ(Adrian et al., 2019). 
As the H. pylori strains used in this are only a small fraction of all identified 
variants it would be beneficial in the future to perform these experiments with 
additional strains of both HopQ types already in use for research of HopQ and 
CEACAM1 binding. Strains already used in previous studies include type I strain P12 
and type II strain 60190. Using strains already within the current literature will allow 
for comparability of our results as the complexity of this host-pathogen interaction 
requires a collaborative approach to understand. 
A final recommended area of expansion for the experiment would be to find 




done to the sites observed on HopQ type I by the Barber Lab. This can be followed by 
mutating the type II sites to see how this impacts binding with CEACAM1.  
Overall, this project has helped start the process of identifying amino acids that 
are important for the binding interaction of HopQ and CEACAM1. The hope for future 
projects would be to use this work to further understand the complex interaction of 
these two proteins. The eventual goal being the prevention of cagA insertion into human 
cells which could result in a significant reduction in H. pylori related gastric cancer 
cases worldwide. It was an honor to work on this project, and I am excited to see what 
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